Skip to main content
Top
Published in: Journal of Cancer Survivorship 2/2015

01-06-2015

Identifying the unmet needs of breast cancer patients post-primary treatment: the Cancer Survivor Profile (CSPro)

Authors: Briana L. Todd, Michael Feuerstein, Amanda Gehrke, Jennifer Hydeman, Lynda Beaupin

Published in: Journal of Cancer Survivorship | Issue 2/2015

Login to get access

Abstract

Purpose

The purpose of this study is to develop a brief measure of problem areas experienced by patients following primary treatment for breast cancer.

Method

Systematic reviews of the quantitative and qualitative literature were used to inform selection of scale items using (1) valid and reliable items from a national item bank (patient reported outcomes measurement information system [PROMIS]), (2) existing scales from prior breast cancer survivorship research, or (3) items developed by the investigators.

Results

Participants (n = 400) were on average 51 years old, highly educated, Caucasian, diagnosed with stage I–III breast cancer, and a median of 1.96 years post-primary treatment. Principal component analysis on a random sample (n = 200) and confirmation on a second random sample (n = 200) indicated that each of the scales under consideration provided a significant measurement model for the symptom burden (CFI = 0.95), health behavior (CFI = 1.00), functional limitation (CFI = 0.99), health care seeking skill (CFI = 0.98), and cancer-related financial strain (CFI = 1.00) broad domains. The median Cronbach’s alpha was 0.91. The measure demonstrated convergent, divergent, construct, and clinical validity. Lower levels of fatigue (β = 0.251. p < 0.000) and pain (β = 0.221, p < 0.000) and greater health competence (β = 0.278, p < 0.000) and physical activity (β = 0.165, p < 0.000) were associated with self-rated global health (F = 60.43, p < 0.000). The final measure consists of 73 items and requires approximately 15 min to complete.

Discussion

The Cancer Survivor Profile (CSPro) provides a profile of problem areas supported by epidemiological and qualitative research on unmet needs of breast cancer survivors.

Implications for Cancer Survivors

Breast cancer survivors can use the CSPro to prioritize problem areas following cancer treatment.
Appendix
Available only for authorised users
Footnotes
1
The CSPro items are available in the public domain. Authors of existing measures provided permission to use items from scales that were available in the scientific literature. The CSPro can easily be uploaded, scored, and displayed on a tablet. Also, the CSPro can be set up to meet Health Insurance Portability and Accountability Act (HIPAA) requirements.
 
Literature
1.
go back to reference De Moor J, Mariotto A, Parry C, Alfano C, Padgett L, Kent E, et al. Cancer survivors in the United States: prevalence across the survivorship trajectory and implications for care. Cancer Epidemiol Biomarkers Prev. 2013;22(4):561–70.PubMedCentralCrossRefPubMed De Moor J, Mariotto A, Parry C, Alfano C, Padgett L, Kent E, et al. Cancer survivors in the United States: prevalence across the survivorship trajectory and implications for care. Cancer Epidemiol Biomarkers Prev. 2013;22(4):561–70.PubMedCentralCrossRefPubMed
2.
go back to reference Shi Q, Smith T, Michonski J, Stein K, Kaw C, Cleeland C. Symptom burden in cancer survivors 1 year after diagnosis—a report from the American cancer society's studies of cancer survivors. Cancer. 2011;117:2779–90.PubMedCentralCrossRefPubMed Shi Q, Smith T, Michonski J, Stein K, Kaw C, Cleeland C. Symptom burden in cancer survivors 1 year after diagnosis—a report from the American cancer society's studies of cancer survivors. Cancer. 2011;117:2779–90.PubMedCentralCrossRefPubMed
3.
go back to reference Elliott J, Fallows A, Staetsky L, Smith P, Foster C, Maher E, et al. The health and well-being of cancer survivors in the UK: findings from a population-based survey. Br J Cancer. 2011;105(105):S11–20.PubMedCentralCrossRefPubMed Elliott J, Fallows A, Staetsky L, Smith P, Foster C, Maher E, et al. The health and well-being of cancer survivors in the UK: findings from a population-based survey. Br J Cancer. 2011;105(105):S11–20.PubMedCentralCrossRefPubMed
4.
go back to reference Hewitt M, Bamundo A, Day R, Harvey C. Perspectives on post-treatment cancer care: qualitative research with survivors, nurses, and physicians. J Clin Oncol. 2007;25(16):2270–3.CrossRefPubMed Hewitt M, Bamundo A, Day R, Harvey C. Perspectives on post-treatment cancer care: qualitative research with survivors, nurses, and physicians. J Clin Oncol. 2007;25(16):2270–3.CrossRefPubMed
5.
go back to reference Rechis R, Beckjord E, Arvey S, Reynolds K, Mcgoldrick D. The essential elements of survivorship care: a livestrong brief. austin, TX: lance Armstrong foundation (Livestrong). 2011. Rechis R, Beckjord E, Arvey S, Reynolds K, Mcgoldrick D. The essential elements of survivorship care: a livestrong brief. austin, TX: lance Armstrong foundation (Livestrong). 2011.
6.
go back to reference Andersen Bl, Derubeis Rj, Berman Bs, Gruman J, Champion Vl, Massie Mj Et Al. Screening, Assessment, and care of anxiety and depressive symptoms in adults with cancer: an american society of Clinical oncology guideline adaptation. J Clin Oncol. 2014:Jco. 2013.52. 4611. Andersen Bl, Derubeis Rj, Berman Bs, Gruman J, Champion Vl, Massie Mj Et Al. Screening, Assessment, and care of anxiety and depressive symptoms in adults with cancer: an american society of Clinical oncology guideline adaptation. J Clin Oncol. 2014:Jco. 2013.52. 4611.
7.
go back to reference Aower J, Bak K, Berger A, Breitbart W, Escalante C, Ganz P, et al. Screening, assessment, and management of fatigue in adult survivors of cancer: an American society of clinical oncology clinical practice guideline adaptation. J Clin Oncol. 2014;32(17):1840–50.CrossRef Aower J, Bak K, Berger A, Breitbart W, Escalante C, Ganz P, et al. Screening, assessment, and management of fatigue in adult survivors of cancer: an American society of clinical oncology clinical practice guideline adaptation. J Clin Oncol. 2014;32(17):1840–50.CrossRef
8.
go back to reference Hershman Dl, Lacchetti C, Dworkin Rh, Smith Eml, Bleeker J, Cavaletti G Et Al. Prevention and management of chemotherapy-induced peripheral neuropathy in survivors of adult cancers: American society of clinical oncology clinical practice guideline. J Clin Oncol. 2014:Jco. 2013.54. 0914. Hershman Dl, Lacchetti C, Dworkin Rh, Smith Eml, Bleeker J, Cavaletti G Et Al. Prevention and management of chemotherapy-induced peripheral neuropathy in survivors of adult cancers: American society of clinical oncology clinical practice guideline. J Clin Oncol. 2014:Jco. 2013.54. 0914.
9.
go back to reference Boyajian R, Grose A, Grenon N, Roper K, Sommer K, Walsh M, et al. Desired elements and timing of cancer survivorship care: one approach may not fit all. J Oncol Prac. 2014;10(5):E293–E8.CrossRef Boyajian R, Grose A, Grenon N, Roper K, Sommer K, Walsh M, et al. Desired elements and timing of cancer survivorship care: one approach may not fit all. J Oncol Prac. 2014;10(5):E293–E8.CrossRef
10.
go back to reference Kukar M, Watroba N, Miller A, Kumar S, Edge S. Fostering coordinated survivorship care in breast cancer: who is lost to follow-up? J Cancer Survivor. 2014;8(2):199–204.CrossRef Kukar M, Watroba N, Miller A, Kumar S, Edge S. Fostering coordinated survivorship care in breast cancer: who is lost to follow-up? J Cancer Survivor. 2014;8(2):199–204.CrossRef
11.
go back to reference Blanch-Hartigan D, Forsythe L, Alfano C, Smith T, Nekhlyudov L, Ganz Pa Et A. Provision and discussion of survivorship care plans among cancer survivors: results of a nationally representative survey of oncologists and primary care physicians. J Clin Oncol. 2014;32(15):1578–85.PubMedCentralCrossRefPubMed Blanch-Hartigan D, Forsythe L, Alfano C, Smith T, Nekhlyudov L, Ganz Pa Et A. Provision and discussion of survivorship care plans among cancer survivors: results of a nationally representative survey of oncologists and primary care physicians. J Clin Oncol. 2014;32(15):1578–85.PubMedCentralCrossRefPubMed
12.
go back to reference Paskett E, Harrop J, Wells K. Patient navigation: an update on the state of the science. Ca: Cancer J Clin. 2011;61(4):237–49. Paskett E, Harrop J, Wells K. Patient navigation: an update on the state of the science. Ca: Cancer J Clin. 2011;61(4):237–49.
13.
go back to reference Kenyon M, Mayer D, Owens A. Late and long‐term effects of breast cancer treatment and surveillance management for the general practitioner. J Obstet Gynecol Neonatal Nurs. 2014;43(3):382–98.CrossRefPubMed Kenyon M, Mayer D, Owens A. Late and long‐term effects of breast cancer treatment and surveillance management for the general practitioner. J Obstet Gynecol Neonatal Nurs. 2014;43(3):382–98.CrossRefPubMed
14.
go back to reference Hambleton R, Russell W. Comparison of classical test theory and item response theory and their application to test development. Educ Meas: Issues Practice. 1993;38–47. Hambleton R, Russell W. Comparison of classical test theory and item response theory and their application to test development. Educ Meas: Issues Practice. 1993;38–47.
15.
go back to reference Streiner D, Norman G.. Health measurement scales—a practical guide to their development and use (second edition). New York: University Press; 1995. Streiner D, Norman G.. Health measurement scales—a practical guide to their development and use (second edition). New York: University Press; 1995.
16.
go back to reference Campbell D, Fiske D. Convergent and discriminant validation by the multitrait-multimethod matrix. Psychol Bull. 1959;56(2):81–105. Campbell D, Fiske D. Convergent and discriminant validation by the multitrait-multimethod matrix. Psychol Bull. 1959;56(2):81–105.
17.
go back to reference Randloff S. The CES-D: a self-report depression scale for research in the general population. Appl Psychol Meas. 1977;1(3):385–401. Randloff S. The CES-D: a self-report depression scale for research in the general population. Appl Psychol Meas. 1977;1(3):385–401.
18.
go back to reference Vodermaier A, Linden W, Siu C. Screening for emotional distress in cancer patients: a systematic review of assessment instruments. J Nat Cancer Inst. 2009;101(21):1464–88.PubMedCentralCrossRefPubMed Vodermaier A, Linden W, Siu C. Screening for emotional distress in cancer patients: a systematic review of assessment instruments. J Nat Cancer Inst. 2009;101(21):1464–88.PubMedCentralCrossRefPubMed
19.
go back to reference Centers for disease control and prevention. behavioral risk factor surveillance questionnaire atlanta, georgia: U.S. department of health and health services, centers for disease control and prevention 2011 january 27, 2011. Centers for disease control and prevention. behavioral risk factor surveillance questionnaire atlanta, georgia: U.S. department of health and health services, centers for disease control and prevention 2011 january 27, 2011.
21.
go back to reference Pierannunzi C, Hu S, Balluz L. A systematic review of publications assessing reliability and validity of the behavioral risk factor surveillance system (BRFSS), 2004–2011. BMC Med Res Methodol. 2013;13(1):49.PubMedCentralCrossRefPubMed Pierannunzi C, Hu S, Balluz L. A systematic review of publications assessing reliability and validity of the behavioral risk factor surveillance system (BRFSS), 2004–2011. BMC Med Res Methodol. 2013;13(1):49.PubMedCentralCrossRefPubMed
22.
go back to reference Buysse D, Reynolds C, Monk T, Berman S, Kupfer D. The Pittsburgh sleep quality index: a new instrument for psychiatric practice and research. Psychiatr Res. 1989;28(2):193–213. Buysse D, Reynolds C, Monk T, Berman S, Kupfer D. The Pittsburgh sleep quality index: a new instrument for psychiatric practice and research. Psychiatr Res. 1989;28(2):193–213.
24.
go back to reference Humpel N, Iverson D. Sleep quality, fatigue and physical activity following a cancer diagnosis. Eur J Cancer Care. 2010;19(6):761–8.CrossRef Humpel N, Iverson D. Sleep quality, fatigue and physical activity following a cancer diagnosis. Eur J Cancer Care. 2010;19(6):761–8.CrossRef
25.
go back to reference Smith M, Winkel G, Egert J, Diaz-Wionczek M, Duhamel K. Patient-physician communication in the context of persistent pain: validation of a modified version of the patients’ perceived involvement in care scale. J Pain Symptom Manag. 2006;32(1):71–81.CrossRef Smith M, Winkel G, Egert J, Diaz-Wionczek M, Duhamel K. Patient-physician communication in the context of persistent pain: validation of a modified version of the patients’ perceived involvement in care scale. J Pain Symptom Manag. 2006;32(1):71–81.CrossRef
26.
go back to reference Fischer D, Fick C. Measuring social desirability: short forms of the Marlowe-Crowne social desirability scale. Educ Psychol Meas. 1993;53:417–24.CrossRef Fischer D, Fick C. Measuring social desirability: short forms of the Marlowe-Crowne social desirability scale. Educ Psychol Meas. 1993;53:417–24.CrossRef
27.
go back to reference Celis-Morales C, Perez-Bravo F, Ibanez L, Salas C, Bailey M, Gill J. Objective vs. self-reported physical activity and sedentary time: effects of measurement method on relationships with risk biomarkers. PLoS ONE. 2012;7(5):E36345.PubMedCentralCrossRefPubMed Celis-Morales C, Perez-Bravo F, Ibanez L, Salas C, Bailey M, Gill J. Objective vs. self-reported physical activity and sedentary time: effects of measurement method on relationships with risk biomarkers. PLoS ONE. 2012;7(5):E36345.PubMedCentralCrossRefPubMed
28.
go back to reference Wu H-S, Harden Jk. Symptom burden and quality of life in survivorship. 2014. Wu H-S, Harden Jk. Symptom burden and quality of life in survivorship. 2014.
29.
go back to reference Halpern Mt, Viswanathan M, Evans T, Birken S, Basch E, Mayer Dk. models of cancer survivorship care: overview and summary of current evidence. J Oncol Prac. 2014:Jop. 2014.001403. Halpern Mt, Viswanathan M, Evans T, Birken S, Basch E, Mayer Dk. models of cancer survivorship care: overview and summary of current evidence. J Oncol Prac. 2014:Jop. 2014.001403.
30.
go back to reference Mc Cabe M, Bhatia S, Oeffinger K, Reaman G, Tyne C, Wollins Ds Et A. American society of clinical oncology statement: achieving high-quality cancer survivorship care. J Clin Oncol. 2013;31(5):631–40. Mc Cabe M, Bhatia S, Oeffinger K, Reaman G, Tyne C, Wollins Ds Et A. American society of clinical oncology statement: achieving high-quality cancer survivorship care. J Clin Oncol. 2013;31(5):631–40.
Metadata
Title
Identifying the unmet needs of breast cancer patients post-primary treatment: the Cancer Survivor Profile (CSPro)
Authors
Briana L. Todd
Michael Feuerstein
Amanda Gehrke
Jennifer Hydeman
Lynda Beaupin
Publication date
01-06-2015
Publisher
Springer US
Published in
Journal of Cancer Survivorship / Issue 2/2015
Print ISSN: 1932-2259
Electronic ISSN: 1932-2267
DOI
https://doi.org/10.1007/s11764-015-0428-0

Other articles of this Issue 2/2015

Journal of Cancer Survivorship 2/2015 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine